U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07843134) titled 'Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery' on Sept. 21.
Brief Summary: This randomized clinical trial will compare suzetrigine with standard analgesia for postoperative pain management after skin cancer surgery.
Adults undergoing Mohs micrographic surgery or wide local excision for cutaneous malignancy or a skin-cancer precursor lesion of the head and neck will be randomized to suzetrigine monotherapy or scheduled acetaminophen plus ibuprofen for 72 hours after surgery. The study uses a double-blind, double-dummy design, and breakthrough oxycodone may be prescribed in either arm on request after same-day clin...